COVID Positive after receiving First, second and booster dose Pfizer COVID Vaccine; COVID Positive after receiving First, second and booster dose Pfizer COVID Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 56-year-old female patient received BNT162b2 (BNT162B2), on 10Apr2021 as dose 1, single (Batch/Lot number: unknown, Expiration Date: Jul2021), in arm, on 19May2021 as dose 2, single (Lot number: EP7534, Expiration Date: Jul2021), in left arm and on 05Nov2021 as dose 3 (booster), single (Lot number: FJ1611) at the age of 55 years, in left arm for covid-19 immunisation.  The patient had no relevant medical history. The patient's concomitant medications were not reported. Past drug history included: Dutasteride for alopecia, notes: Caller was taking Dutasteride, Doxycycline, estradiol cream, Oracea and Clobetasol propionate, which is a minoxidil cream.; Doxycycline, notes: Caller was taking Dutasteride, Doxycycline, estradiol cream, Oracea and Clobetasol propionate, which is a minoxidil cream.; Estradiol cream, notes: Caller was taking Dutasteride, Doxycycline, estradiol cream, Oracea and Clobetasol propionate, which is a minoxidil cream.; Oracea, notes: Caller was taking Dutasteride, Doxycycline, estradiol cream, Oracea and Clobetasol propionate, which is a minoxidil cream.; Clobetasol propionate, notes: Caller was taking Dutasteride, Doxycycline, estradiol cream, Oracea and Clobetasol propionate, which is a minoxidil cream. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID Positive after receiving First, second and booster dose Pfizer COVID Vaccine". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional Information: Paxlovid: The patient took three pills twice a day, is taking a 5-day course. The patient has a really bad taste in mouth: Began when started taking Paxlovid on 14Jun2022 and is persisting. Reporter had stopped taking medication. Doesn't have any major health issues that takes medicine for. The patient was able to stop taking medications was taking. Clarifies medications reporter stopped taking were o stopped taking everything else. Doesn't have any major luckily health issues that take medicine for and able to stop what was taking. medications: told not to take Dutasteride for alopecia condition, Doxycycline, and estradiol cream. Told to stop taking Dutasteride, said could take Doxycycline, but reporter stopped taking Doxycycline. Would like to mention knows that there was a study result that came out the next day after reporter started taking Paxlovid that discontinued study of Paxlovid in people that didn't' have high probability of getting sick from COVID. Reporter is vaccinated. Doesn't think Paxlovid really worked, not very effective. Did not feel better really until today, 17Jun2022 and started taking Paxlovid on 14Jun2022. Doesn't know if Paxlovid helped or didn't, feels like there was nothing immediate. Reporter is Vaccinated: Clarifies receive Pfizer COVID Vaccine including one booster dose. Reporter was taking Dutasteride, Doxycycline, estradiol cream, Oracea and Clobetasol propionate, which is a minoxidil cream. Additional Vaccines not administered on Same Date of the Pfizer Suspect If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect. The patient did not receive prior vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s). AE(s) following prior vaccinations: No, not that aware of. relevant Tests: none.   Description of Product Complaint: Eyes have to keep blinking while providing NDC/lot/expiration because print is small on Paxlovid. Doesn't really think Paxlovid worked, was not very effective. Product strength and count size dispensed: 5-day course, three pills twice a day. COVID Positive after receiving first, second, and booster dose Pfizer COVID Vaccine. Product strength and count size dispensed: Adult dose Additional lot numbers: First dose: EP7534, second dose: EW0153 or EW01S3, booster dose: FJ1611. Additional lot numbers: N/A. Is a sample of the product not available to be returned. Packaging sealed and intact. Yes   No follow-up attempts are needed. No further information is expected.